Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children
Commercial real estate and your practice, part two with Colin Carr
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management
Mental health and ophthalmology